M.D., CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger Health
Stephen M. Hahn, M.D. is CEO-Partner of Flagship Pioneering and Chief Executive Officer of Harbinger Health. Dr. Hahn served as the 24th U.S. Food and Drug Administration (FDA) Commissioner from 2019 to 2021 overseeing COVID and non-COVID regulatory affairs. Previously, Dr. Hahn held executive roles at MD Anderson Cancer Center, including chief medical executive and deputy president and chief operating officer, as well as other positions. Prior to joining MD Anderson, Dr. Hahn led radiation oncology at the University of Pennsylvania’s Perelman School of Medicine. Dr. Hahn earned his M.D. from Temple University and B.A. in Biology from Rice University.